SE7712431L - Tienamycin - Google Patents

Tienamycin

Info

Publication number
SE7712431L
SE7712431L SE7712431A SE7712431A SE7712431L SE 7712431 L SE7712431 L SE 7712431L SE 7712431 A SE7712431 A SE 7712431A SE 7712431 A SE7712431 A SE 7712431A SE 7712431 L SE7712431 L SE 7712431L
Authority
SE
Sweden
Prior art keywords
tienamycin
Prior art date
Application number
SE7712431A
Other languages
English (en)
Other versions
SE436034B (sv
Inventor
B G Christensen
D B R Johnston
S M Schmitt
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE7712431L publication Critical patent/SE7712431L/sv
Publication of SE436034B publication Critical patent/SE436034B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/39—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups
    • C07C205/42—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups or esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/26—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7712431A 1976-11-19 1977-11-03 Forfarande for framstellning av 3-(2-aminoetyltio)-6-(1-hydroxietyl)-7-oxo-1-azabicyklo/3.2.0/hept-2-en-2-karboxylsyra SE436034B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74336576A 1976-11-19 1976-11-19
US79207177A 1977-04-28 1977-04-28
US83321077A 1977-09-15 1977-09-15

Publications (2)

Publication Number Publication Date
SE7712431L true SE7712431L (sv) 1978-05-20
SE436034B SE436034B (sv) 1984-11-05

Family

ID=27419293

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7712431A SE436034B (sv) 1976-11-19 1977-11-03 Forfarande for framstellning av 3-(2-aminoetyltio)-6-(1-hydroxietyl)-7-oxo-1-azabicyklo/3.2.0/hept-2-en-2-karboxylsyra

Country Status (7)

Country Link
JP (1) JPS5365892A (sv)
DE (1) DE2751597A1 (sv)
DK (1) DK488077A (sv)
FR (1) FR2424921A1 (sv)
GB (1) GB1589896A (sv)
NL (1) NL7712093A (sv)
SE (1) SE436034B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU531084B2 (en) * 1977-10-19 1983-08-11 Merck & Co., Inc. Azetidine derivatives
AU4061378A (en) * 1977-10-19 1980-04-17 Merck & Co., Inc. 1-azabicyclo (3.2.0) hept-2-enes
EP0002564B1 (en) * 1977-11-12 1984-06-20 Beecham Group Plc Derivatives of 7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid, their preparation, pharmaceutical compositions containing them and intermediates
DE2966187D1 (en) * 1978-08-23 1983-10-27 Beecham Group Plc Beta-lactam antibacterial compounds, their preparation and pharmaceutical compositions containing them
EP0082133A3 (en) * 1979-04-19 1983-07-20 Merck & Co. Inc. A process for preparing intermediates useful for preparing 2-substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids
EP0018594B1 (en) * 1979-04-27 1985-08-21 Merck & Co. Inc. Process for the preparation of 3-(1-hydroxyethyl)-azetidinones
EP0028151A1 (en) * 1979-10-29 1981-05-06 Beecham Group Plc Process for the preparation of antibiotics
US4309346A (en) * 1980-03-27 1982-01-05 Merck & Co., Inc. Process for the preparation of 1-carbapenems and intermediates via trithioorthoacetates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK143712C (da) * 1975-11-21 1982-03-22 Merck & Co Inc Fremgangsmaade til fremstilling af de antibiotiske stoffer 890a1 og 890a3

Also Published As

Publication number Publication date
DK488077A (da) 1978-05-20
GB1589896A (en) 1981-05-20
SE436034B (sv) 1984-11-05
JPS5365892A (en) 1978-06-12
FR2424921A1 (fr) 1979-11-30
NL7712093A (nl) 1978-05-23
DE2751597A1 (de) 1978-05-24
JPS6319514B2 (sv) 1988-04-22
FR2424921B1 (sv) 1982-09-10

Similar Documents

Publication Publication Date Title
ATA204777A (de) Schischu
ATA870576A (de) Siebfeld
AT353866B (de) Hoergeraet
AT349288B (de) Ruehrwerksmuehle
ATA39777A (de) Raffstore
ATA505377A (de) Ruehrwerksmuehle
BE854877A (fr) Batterie-fer-argent
SE404262B (sv) Molnhojdsmetare
AT346259B (de) Webschaft
AT378100B (de) Halmerntegeraet
ATA307077A (de) Elektrokardioskop
SE7712431L (sv) Tienamycin
BE850832A (fr) Mofbuis
AT349360B (de) Unmagnetische tretmine
FI773518A (fi) Tvaokomponent-diazotypimaterial
BE846205A (fr) M-alkyldiphenylamines
AT356609B (de) Kristallisator
ATA546877A (de) Kruemelwalze
ATA75676A (de) Springmine
BE850709A (fr) Acetanilido-piperazines
AT346041B (de) Sheddach
AT356871B (de) Saegegatter
FI773185A (fi) Dispenserfoerpackning
ATA115877A (de) Deodorantien
JPS51109549A (ja) Reitosokoyoreikyakushitsunoreikyakuhoho

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7712431-1

Effective date: 19880322

Format of ref document f/p: F